Abortion drug could help reduce risk of breast cancer, group of medics says

According to an international group of doctors and scientists, the abortion drug mifepristone could help reduce the risk of breast cancer in women at high risk. The experts, writing in The Lancet, claim that "stigma" around the drug is preventing pharmaceutical companies from exploring its potential as a new preventive treatment. The article suggests that further research is needed to investigate the possible benefits of using mifepristone to lower the risk of breast cancer in women, but the negative perception surrounding the drug is hindering progress in this area of reproductive health.
Source: For the complete article, please visit the original source link below.